← Leaderboards
Steven Prestrelski
Xeris Pharmaceuticals, Inc.
$2,954,783
Attributed
$6,503,772
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2012–18$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$6,503,772 · 4
By mechanism
R44$6,503,772 · 4
Top collaborators
- Eyal Dassau3 shared
- Mary E Patti3 shared
- Paul Thornton3 shared
- James C. Cloyd2 shared
- W. Kenneth Ward2 shared
Most similar at Xeris Pharmaceuticals, Inc.
Same institution · by research overlap
- John Kinzell$1,476,967
- Paul Thornton$1,036,601
Others in their field
Top investigators on “Safety”
- David Heimbrook · Leidos Biomedical Research, Inc.$398,099,186
- Lawrence Corey · Fred Hutchinson Cancer Center$396,952,463
- Mitchell J Malone · Texas A&M Research Foundation$329,191,208
- Gary D Acton · University Of California-Davis$320,373,312
- Melynda Holmes · Technical Resources Inc$232,659,786
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
Research focus
SafetyDesignClinical TrialsProgramsLifeBaseBlood GlucosePumpResponseTemperatureGlucagonConduct Clinical TrialsVial DeviceHypoglycemiaAnimalsRattusDrug KineticsPharmaceutical PreparationsDoseSubcutaneousSyringesInfusion PumpsFormulationEvent
Grant awards (10)
Auto-Injectable Diazepam Formulation for Rapid Treatment of Uncontrolled Seizures$793,851
R44 · FY2018 · NS · contact PI
Auto-Injectable Diazepam Formulation for Rapid Treatment of Uncontrolled Seizures$797,247
R44 · FY2017 · NS · contact PI
CSI Glucagon for Treatment of Congenital Hyperinsulinism$754,662
R44 · FY2017 · DK · contact PI
Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia$405,006
R44 · FY2017 · DK · contact PI
CSI Glucagon for Treatment of Congenital Hyperinsulinism$833,136
R44 · FY2016 · DK · contact PI
Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia$816,080
R44 · FY2016 · DK · contact PI
Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia$561,530
R44 · FY2015 · DK · contact PI
CSI Glucagon for Treatment of Congenital Hyperinsulinism$485,403
R44 · FY2015 · DK · contact PI
Clinical Development of a Stable Glucagon Formulation for Bi-hormonal Pump$713,733
R44 · FY2013 · DK · contact PI
Clinical Development of a Stable Glucagon Formulation for Bi-hormonal Pump$343,124
R44 · FY2012 · DK · contact PI